Souvik Banerjee1, Louis P Garrison2, David R Flum3, David E Arterburn4. 1. Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. 2. Department of Pharmacy, University of Washington, Seattle, Washington, USA. 3. Departments of Medicine and Surgery, University of Washington, Seattle, Washington, USA. 4. Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Abstract
OBJECTIVE: The aim of this study was to compare the cost and health care utilization of patients with obesity and type 2 diabetes mellitus (T2DM) randomized into either Roux-en-Y gastric bypass (RYGB) surgery or an intensive lifestyle and medical intervention (ILMI). METHODS: This analysis (N = 745) is based on 2-year follow-up of a small randomized controlled trial (RCT); adult patients with obesity and T2DM were recruited between 2011 and 2012 from Kaiser Permanente Washington. Comparisons were made for patients randomized into either RYGB (N = 15) or ILMI (N = 17). RESULTS: There were no significant cost savings for RYGB versus ILMI patients through the follow-up years. Pharmacy cost was lower for RYGB versus ILMI patients by about $900 in year 2 versus year 0; however, inpatient and emergency room costs were higher for surgery patients in follow-up years relative to year 0. Median total cost for nonrandomized patients was higher in year 0 and in year 2 compared to randomized patients. CONCLUSIONS:Bariatric surgery is not cost saving in the short term. Moreover, the costs of patients who enter into RCTs of RYGB may differ from the costs of those who do not enter RCTs, suggesting use of caution when using such data to draw inferences about the general population with obesity.
RCT Entities:
OBJECTIVE: The aim of this study was to compare the cost and health care utilization of patients with obesity and type 2 diabetes mellitus (T2DM) randomized into either Roux-en-Y gastric bypass (RYGB) surgery or an intensive lifestyle and medical intervention (ILMI). METHODS: This analysis (N = 745) is based on 2-year follow-up of a small randomized controlled trial (RCT); adult patients with obesity and T2DM were recruited between 2011 and 2012 from Kaiser Permanente Washington. Comparisons were made for patients randomized into either RYGB (N = 15) or ILMI (N = 17). RESULTS: There were no significant cost savings for RYGB versus ILMI patients through the follow-up years. Pharmacy cost was lower for RYGB versus ILMI patients by about $900 in year 2 versus year 0; however, inpatient and emergency room costs were higher for surgery patients in follow-up years relative to year 0. Median total cost for nonrandomized patients was higher in year 0 and in year 2 compared to randomized patients. CONCLUSIONS: Bariatric surgery is not cost saving in the short term. Moreover, the costs of patients who enter into RCTs of RYGB may differ from the costs of those who do not enter RCTs, suggesting use of caution when using such data to draw inferences about the general population with obesity.
Authors: Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel Journal: Ann Fam Med Date: 2009 Sep-Oct Impact factor: 5.166
Authors: Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò Journal: Nat Rev Neurosci Date: 2013-04-10 Impact factor: 34.870
Authors: Matthew L Maciejewski; Edward H Livingston; Valerie A Smith; Leila C Kahwati; William G Henderson; David E Arterburn Journal: Arch Surg Date: 2012-07
Authors: Jonathan P Weiner; Suzanne M Goodwin; Hsien-Yen Chang; Shari D Bolen; Thomas M Richards; Roger A Johns; Soyal R Momin; Jeanne M Clark Journal: JAMA Surg Date: 2013-06 Impact factor: 14.766
Authors: David Arterburn; David R Flum; Emily O Westbrook; Sharon Fuller; Mary Shea; Steven N Bock; Jeffrey Landers; Katie Kowalski; Emily Turnbull; David E Cummings Journal: Surg Obes Relat Dis Date: 2013-06-04 Impact factor: 4.734
Authors: Pierre-Yves Cremieux; Henry Buchwald; Scott A Shikora; Arindam Ghosh; Haixia Elaine Yang; Marric Buessing Journal: Am J Manag Care Date: 2008-09 Impact factor: 2.229